⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 8, 2023Yearbook of pediatric endocrinology

Crinecerfont, a CRF1 receptor antagonist, lowers adrenal androgens in adolescents with congenital adrenal hyperplasia

Ron S. Newfield Kyriakie Sarafoglou Patricia Y. Fechner Natalie Nokoff Richard J. Auchus Maria G. Vogiatzi George Jeha Nagdeep Giri Eiry Roberts Julia Sturgeon Jean L. Chan Robert Farber

View at Publisher

Ask AI

Bookmark

Share

Abstract

Brief summary: This study evaluated the safety, tolerability and efficacy of Crinecerfont, a CRF1R antagonist in adolescents with classic congenital adrenal hyperplasia (CAH).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Newfield et al. (2023) studied this question.

synapsesocial.com/papers/6a747c3d1646b2abe50326ad https://doi.org/10.1530/ey.20.6.6

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Explainable TabNet for gestational diabetes prediction with physician-in-the-loop and multi-site clinical validationYearbook of pediatric endocrinology · Sat,
2Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised studyThe Lancet Diabetes & Endocrinology · Fri,
3Modeling human prenatal adrenocortical functional zonation dynamics from pluripotent stem cellsYearbook of pediatric endocrinology · Sun,
4Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complicationsYearbook of pediatric endocrinology · Fri,
5Global burden of type 2 diabetes in adolescents and young adults, 19902019: systematic analysis of the Global Burden of Disease Study 2019Yearbook of pediatric endocrinology · Fri,

More from Yearbook of pediatric endocrinology

Impaired bone strength and bone microstructure in a novel early-onset osteoporotic rat model with a clinically relevant PLS3 mutationFri,
Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the omnigenic sparse effector hypothesis of complex trait geneticsFri,
Child health, developmental plasticity, and epigenetic programmingFri,
Juvenility in the context of life history theoryFri,
International recommendations for the diagnosis and management of patients with adrenoleukodystrophy: A consensus-based approachFri,